Regulation of Amphiregulin mRNA by TGF-beta in the Human Lung Adenocarcinoma Cell Line A549

被引:18
|
作者
Bennett, Kelly L. [1 ]
Plowman, Gregory D. [1 ]
Buckley, Sharon D. [1 ]
Skonier, John [1 ]
Purchio, A. F. [1 ]
机构
[1] Bristol Myers Squibb, Seattle, WA 98121 USA
关键词
TCF-beta; AR; EGF; growth inhibition;
D O I
10.3109/08977199209046925
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Transforming growth factor beta is a strong growth inhibitor for many types of normal and transformed cells, although little is known on the mechanism of this anti-proliferative effect. The human lung adenocarcinoma cell line A549 is growth arrested by TGF-beta 1 and serves as a model for studying this effect. We describe that, concurrent with the inhibition of A549 cell growth, TGF-beta 1 treatment causes a dramatic reduction in the level of expression of the amphiregulin (AR) gene, a recently identified member of the EGF/TGF alpha family. Similar results were also observed with TGF-beta 2. Peak inhibition occurred at 24 hr of treatment and was reversible upon removal of TGF-beta 1. The level of AR protein secreted by A549 cells was also decreased by TGF-beta 1. In contrast, TGF-alpha mRNA was not detected in these cells regardless of TGF-beta 1 treatment. Another TGF-beta inhibited cell line, PC-3 (human prostatic adenocarcinoma) also exhibited a decrease in AR message levels following exposure to TGF-beta 1. The growth inhibitory effects of TGF-beta may in part be mediated by modulation of AR expression.
引用
收藏
页码:207 / 213
页数:8
相关论文
共 50 条
  • [1] Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines
    Xu, Cheng-Cheng
    Wu, Lei-Ming
    Sun, Wei
    Zhang, Ni
    Chen, Wen-Shu
    Fu, Xiang-Ning
    MOLECULAR MEDICINE REPORTS, 2011, 4 (05) : 1007 - 1015
  • [2] Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549
    Zheng, Qijun
    Qin, Hongyan
    Zhang, Hongwei
    Li, Junchang
    Hou, Lihong
    Wang, Hongbin
    Zhang, Xueping
    Zhang, Suzhen
    Feng, Lei
    Liang, Yingmin
    Han, Hua
    Yi, Dinghua
    ONCOLOGY REPORTS, 2007, 17 (04) : 847 - 852
  • [3] EXPRESSION DIFFERENCES OF VASCULAR GROWTH FACTORS IN HUMAN LUNG ADENOCARCINOMA CELL LINE A549 AND CISPLATIN-RESISTANT HUMAN LUNG ADENOCARCINOMA CELL LINE A549DDP
    李西平
    王曾礼
    蒋薇
    王洁
    刘叙仪
    张毅
    刘元林
    Medical Bulletin of Shanghai Jiaotong University, 2003, (01) : 16 - 20
  • [4] Antitumor Activity of Acriflavine in Lung Adenocarcinoma Cell Line A549
    Lee, Chia-Jen
    Yue, Chia-Herng
    Lin, Yu-Jie
    Lin, Yu-Yu
    Kao, Shao-Hsuan
    Liu, Jer-Yuh
    Chen, Yieng-How
    ANTICANCER RESEARCH, 2014, 34 (11) : 6467 - 6472
  • [5] The influences of TGF-β1 upon the human adenocarcinoma cell of lung A549 and cellular immunity
    Li, Min-Jie
    Wang, Xi
    Chen, Ying
    Li, Guang-Jian
    Zhao, Guang-Qiang
    Xiang, Bing-Quan
    Wei, Xue-Qiang
    Lei, Yu-Jie
    Huang, Yun-Chao
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (17)
  • [6] EVIDENCE FOR THROMBOXANE BIOSYNTHESIS IN A HUMAN-LUNG ADENOCARCINOMA CELL-LINE, A549
    HUBBARD, WC
    ALLEY, MC
    MCLEMORE, TL
    BOYD, MR
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 692 - 692
  • [7] Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549
    Ye, Bin
    Xie, Yan
    Qin, Zheng-hong
    Wu, Jun-chao
    Han, Rong
    He, Jing-kang
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (11) : 1397 - 1401
  • [8] Anti-tumor activity of CrTX in human lung adenocarcinoma cell line A549
    Bin Ye
    Yan Xie
    Zheng-hong Qin
    Jun-chao Wu
    Rong Han
    Jing-kang He
    Acta Pharmacologica Sinica, 2011, 32 : 1397 - 1401
  • [9] Curcumin induced autophagy anticancer effects on human lung adenocarcinoma cell line A549
    Liu, Furong
    Gao, Song
    Yang, Yuxuan
    Zhao, Xiaodan
    Fan, Yameng
    Ma, Wenxia
    Yang, Danrong
    Yang, Aimin
    Yu, Yan
    ONCOLOGY LETTERS, 2017, 14 (03) : 2775 - 2782
  • [10] Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro
    Chen, Xiang-Qi
    Wang, Yu-Lan
    Li, Zhi-Ying
    Lin, Ting-Yan
    MOLECULAR MEDICINE REPORTS, 2014, 10 (01) : 347 - 352